Skip to main content

MoneyWorks4Me

Indoco Remedies - Quaterly Results

01 Feb 2022 Evaluate
The company witnessed a 7.78% growth in the revenue at Rs. 3577.60 millions for the quarter ended December 2021 as compared to Rs. 3319.40 millions during the year-ago period.Good  Net Profit growth of 31.15% reported above the corresponding previous quarter figure of Rs. 251.40 millions to Rs. 329.70 millioins.OP of the company witnessed a marginal growth to 735.60 millions from 603.30 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 3577.60 3319.40 7.78 11308.40 9354.50 20.89 12403.00 11060.00 12.14
Other Income 1.60 3.70 -56.76 20.30 11.50 76.52 31.20 24.30 28.40
PBIDT 735.60 603.30 21.93 2485.60 1701.50 46.08 2266.90 1257.70 80.24
Interest 38.10 60.30 -36.82 111.00 176.70 -37.18 222.20 262.50 -15.35
PBDT 697.50 543.00 28.45 2374.60 1524.80 55.73 2044.70 995.20 105.46
Depreciation 192.20 168.80 13.86 609.10 545.80 11.60 731.20 708.10 3.26
PBT 505.30 374.20 35.03 1765.50 979.00 80.34 1313.50 287.10 357.51
TAX 175.60 122.80 43.00 624.00 304.20 105.13 389.60 44.60 773.54
Deferred Tax 18.40 5.80 217.24 -70.00 -91.50 -23.50 4.90 44.60 -89.01
PAT 329.70 251.40 31.15 1141.50 674.80 69.16 923.90 242.50 280.99
Equity 184.30 184.30 0.00 184.30 184.30 0.00 184.30 184.30 0.00
PBIDTM(%) 20.56 18.17 13.13 21.98 18.19 20.84 18.28 11.37 60.72
Peers
Company Name CMP
Sun Pharma. Inds. 1811.90
Dr. Reddys Labs. 1359.20
Cipla 1374.10
Lupin 2017.20
Zydus Lifesciences 1244.15
View more..